Join Our Clinical Study to Support the Development of Noninvasive Prenatal Testing
The study is collecting blood samples to help researchers create and improve future blood-based prenatal screening tests that can detect certain genetic conditions in a fetus—with minimal risk to the mother or baby.
Qualified participants will receive the opportunity to contribute to research that may help improve the accuracy and availability of future prenatal screening tests as well as the satisfaction of supporting scientific advancement in a way that may help future families. Compensation for participation may also be provided.
Minimum Eligibility Criteria May Include the Following:
- Currently pregnant with either one baby or twins
- At least 9 weeks pregnant at time of enrollment
- Have received abnormal test results from:
- A noninvasive prenatal test (NIPT), and/or
- A diagnostic procedure (such as Chorionic Villus Sampling [CVS] or amniocentesis) as part of your prenatal care
Additional criteria will be evaluated to determine eligibility.
What is the purpose of this study?
To help develop and validate more accurate and reliable noninvasive prenatal tests (NIPT) for detecting certain genetic conditions in a fetus. This study is focused on advancing prenatal care by making testing safer, more accessible, and more accurate for future families.
Why Are These Studies Important?
This study will support the development of safer, more accurate, and more accessible noninvasive prenatal tests (NIPT) that can help detect certain genetic conditions in a pregnancy—early and with minimal risk to the mother or baby. By contributing to research with real-world samples, this study helps improve the reliability of future prenatal screening tools, giving expectant families more information and peace of mind during pregnancy.
What Is a Clinical Research Study?
A clinical research study helps researchers evaluate new medical approaches—such as medications, diagnostic tests, or procedures—before they are widely used in clinical care. Some studies test treatments, while others, like this one, focus on improving and validating screening methods. These studies are essential for advancing medical care and improving outcomes for future patients.
Ask your doctor if this study is right for you.
For general questions, you may also call Medical Colleagues of Texas at (281) 769-8674.